phrykt

Alkermes plc. (ALKS): who owns it and who trades it

As of Nov 16, 2026, ALKS insiders reported 33 open-market sales worth $10.1M and no purchases in the last 12 months, with 71% of the sale value made under pre-set 10b5-1 plans. The largest seller was Craig C. Hopkinson (Vice president), with $3.4M. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Alkermes

From the latest filings

Overall: more buying than selling. Insiders mostly sold. Famous investors and Congress mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns ALKS

422 funds and institutions reported ALKS shares worth $9.6B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 17.5%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.17.5%
California State Teachers Retirement System6.2%
Baker Bros. Advisors LP6.0%
Vanguard Portfolio Management LLC5.7%
State Street Corp5.5%
Vanguard Capital Management LLC4.5%
T. Rowe Price Associates4.0%
Renaissance Technologies LLC3.9%
Geode Capital Management, LLC2.7%
Dimensional Fund Advisors LP2.5%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.29.24M17.54%$1.5B+3%
California State Teachers Retirement System10.34M6.21%$197M+5528%
Baker Bros. Advisors LP10.01M6.01%$525MNo change
Vanguard Portfolio Management LLC9.49M5.69%$497M-0%
State Street Corp9.16M5.50%$480M-3%
Vanguard Capital Management LLC7.52M4.51%$394M+1%
T. Rowe Price Associates6.74M4.04%$353M+44%
Renaissance Technologies LLC6.46M3.88%$339M+5%
Geode Capital Management, LLC4.48M2.69%$235M+7%
Dimensional Fund Advisors LP4.19M2.52%$220M-7%
Deep Track Capital, LP4.00M2.40%$210M+11%
American Century Companies Inc3.95M2.37%$207M-35%
Holocene Advisors, LP3.60M2.16%$189M+55%
Commodore Capital LP3.00M1.80%$157M-29%
Wellington Management Group LLP2.81M1.69%$147M-5%
Primecap Management Co2.53M1.52%$132M-0%
First Trust Advisors LP2.42M1.45%$127M-18%
Charles Schwab Investment Management Inc2.34M1.40%$122M+4%
Sixth Street Partners Management Company, L.P.2.34M1.40%$122M–
Nuveen, LLC2.32M1.39%$122M-6%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, ALKS insiders reported $0 of open-market purchases and $10.1M of sales. 71% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$10.1M
33 trades, 7 people
Sales under a 10b5-1 plan
71%
Share of sale value
Latest trade
Nov 3, 2026
Filed Nov 3, 2026

Purchases and sales by month

$3.1M$3.1MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 3, 2026David Joseph GaffinVice presidentSale plan2,035$46.17$94KForm 4
Oct 2, 2026David Joseph GaffinVice presidentSale plan2,034$41.03$83.5KForm 4
Sep 3, 2026David Joseph GaffinVice presidentSale plan2,034$48.01$97.7KForm 4
Sep 1, 2026Craig C. HopkinsonVice presidentSale plan9,000$46.99$423KForm 4
Aug 17, 2026Christian Todd NicholsVice presidentSale plan664$49.65$33KForm 4
Aug 17, 2026Christian Todd NicholsVice presidentSale plan6,912$49.19$340KForm 4
Aug 3, 2026nancy lynn MD snydermanDirectorSale44,472$50.35$2.2MForm 4
Aug 3, 2026Craig C. HopkinsonVice presidentSale plan9,000$48.58$437KForm 4
Aug 3, 2026David Joseph GaffinVice presidentSale plan2,034$48.58$98.8KForm 4
Jul 6, 2026David Joseph GaffinVice presidentSale plan2,034$54.03$110KForm 4
Jul 1, 2026Craig C. HopkinsonVice presidentSale plan700$52.13$36.5KForm 4
Jul 1, 2026Craig C. HopkinsonVice presidentSale plan8,300$51.46$427KForm 4
Jun 12, 2026Christopher I WrightDirectorSale plan2,000$45.10$90.2KForm 4
Jun 4, 2026David Joseph GaffinVice presidentSale plan2,034$43.05$87.6KForm 4
Jun 1, 2026Craig C. HopkinsonVice presidentSale plan9,000$41.67$375KForm 4
May 29, 2026Samuel Joseph ParisiVice presidentSale16,217$42.36$687KForm 4
May 4, 2026David Joseph GaffinVice presidentSale plan2,034$33.20$67.5KForm 4
May 1, 2026Craig C. HopkinsonVice presidentSale plan9,000$33.40$301KForm 4
Apr 6, 2026David Joseph GaffinVice presidentSale plan2,034$34.57$70.3KForm 4
Apr 1, 2026Craig C. HopkinsonVice presidentSale plan9,000$35.51$320KForm 4
Mar 3, 2026David Joseph GaffinVice presidentSale plan2,034$29.76$60.5KForm 4
Mar 2, 2026Samuel Joseph ParisiVice presidentSale plan6,890$29.29$202KForm 4
Mar 2, 2026Christian Todd NicholsVice presidentSale plan6,000$30.00$180KForm 4
Mar 2, 2026Craig C. HopkinsonVice presidentSale plan9,000$29.72$267KForm 4
Mar 2, 2026David Joseph GaffinVice presidentSale plan2,034$29.29$59.6KForm 4
Feb 2, 2026Craig C. HopkinsonVice presidentSale plan5,000$34.24$171KForm 4
Feb 2, 2026Craig C. HopkinsonVice presidentSale plan4,000$33.54$134KForm 4
Feb 2, 2026Shane CookeDirectorSale plan32,113$34.78$1.1MForm 4
Feb 2, 2026Shane CookeDirectorSale plan29,087$34.34$999KForm 4
Jan 8, 2026Craig C. HopkinsonVice presidentSale plan5,000$30.00$150KForm 4
Jan 2, 2026Craig C. HopkinsonVice presidentSale plan4,000$28.00$112KForm 4
Dec 3, 2025Craig C. HopkinsonVice presidentSale plan3,748$30.00$112KForm 4
Dec 1, 2025Craig C. HopkinsonVice presidentSale plan4,000$29.30$117KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Craig C. HopkinsonEVP R&D, Chief Medical Officer–$3.4MSep 1, 2026
nancy lynn MD snydermanDirector–$2.2MAug 3, 2026
Shane CookeDirector–$2.1MFeb 2, 2026
Samuel Joseph ParisiVP, Finance (Interim PAO)–$889KMay 29, 2026
David Joseph GaffinEVP, CLO, Alkermes, Inc.–$829KNov 3, 2026
Christian Todd NicholsSVP, Chief Commercial Officer–$553KAug 17, 2026
Christopher I WrightDirector–$90.2KJun 12, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

ALKS short interest

High short interest. 11.7% of ALKS shares are sold short: about 1 share in 9. Over the last 12 reports the number of shares short went up 7%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 19.65M ALKS shares were sold short, 11.7% of the shares outstanding, up 3.1% from the report before. At the average daily volume of 1.75M shares, buying them all back would take about 11.2 trading days (days to cover).

Shares short, % of all shares

11.7%May 15Oct 3012.2%

Days to cover

11.2May 15Oct 3012.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202619.65M11.69%+3%1.75M11.2
Oct 15, 202619.05M11.35%+7%2.09M9.1
Sep 30, 202617.82M10.62%+18%2.84M6.3
Sep 15, 202615.16M9.03%+3%1.42M10.7
Aug 31, 202614.72M8.77%-0%1.25M11.8
Aug 14, 202614.76M8.80%+2%1.45M10.2
Jul 31, 202614.41M8.59%-4%1.87M7.7
Jul 15, 202615.02M9.01%-14%1.65M9.1
Jun 30, 202617.46M10.48%-3%3.63M4.8
Jun 15, 202617.96M10.78%+4%1.90M9.5
May 29, 202617.36M10.41%-5%2.05M8.4
May 15, 202618.28M10.97%-8%2.42M7.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded ALKS

Since Nov 17, 2024, 1 member of Congress reported 2 purchases and 0 sales of ALKS. The latest was a purchase by Gilbert Ray Cisneros, Jr. on Sep 29, 2026, reported Oct 12, 2026.

Purchases 2Sales 0

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Sep 29, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfOct 12, 2026Report
Jul 30, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$15K–$50KSelfSep 4, 2026Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Alkermes company events

Alkermes filed 17 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Nov 3, 2026.

  1. Nov 3, 2026ResultsReleased financial results. Filing
  2. Sep 21, 2026AnnouncementOf this Current Report on Form 8-K. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. Filing
  3. Sep 16, 2026LeadershipThe board of directors of Alkermes plc increased the size of the Board from ten (10) to eleven (11) directors and appointed Anne C. Whitaker to the Board, effective immediately, with an initial term expiring at the Company’s 2027 annual general meeting of shareholders. Filing
  4. Aug 12, 2026AgreementAlkermes plc entered into Amendment No. 1 to Credit Agreement, which amends the Credit Agreement, dated as of February 12, 2026, among the Company, as the TopCo Borrower, Alkermes, Inc., as the U.S. Borrower, Alkermes Finance LLC, as the U.S. Co-Borrower, JPMorgan Chase Bank, N.A., as… Filing
  5. Aug 3, 2026LeadershipAmended an earlier report. Of the Original Form 8-K to provide information regarding additional actions taken by the Board in connection with Mr. Jackson’s appointment, including (i) information regarding the compensation awarded to Mr. Jackson, which was not yet determined at the time of filing of the Original Form 8-K and… Filing
  6. Jul 28, 2026ResultsReleased financial results. Filing
  7. Jul 8, 2026AgreementEnded an important agreement. Filing
  8. Jun 15, 2026AnnouncementOf this Current Report on Form 8-K. A copy of the related press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. Filing
  9. May 20, 2026LeadershipAt the 2026 annual general meeting of shareholders of Alkermes plc, the Company’s shareholders approved amendments to the Alkermes plc 2018 Stock Option and Incentive Plan to, among other things, increase the number of the Company’s ordinary shares authorized for issuance thereunder by 5,900,000… Filing
  10. May 12, 2026AnnouncementOf this Current Report on Form 8-K. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. Filing
  11. May 5, 2026ResultsReleased financial results. Filing
  12. Feb 25, 2026LeadershipRichard F. Pops, Chairman and Chief Executive Officer of Alkermes plc, notified the Company’s board of directors of his decision to retire from his position of Chief Executive Officer, effective July 31, 2026, following a distinguished 35 years of service in this role. Filing
  13. Feb 25, 2026ResultsReleased financial results. Filing
  14. Feb 12, 2026DealBelow) and the Company’s entry into the Credit Agreement (as described in Item 1.01 above), the Company terminated the previously disclosed amended and restated bridge term loan credit agreement by and among the Company, as the TopCo Borrower, Alkermes, Inc., as the U.S. Borrower, JPMorgan Chase… Filing
  15. Jan 12, 2026ResultsReleased financial results. Filing
  16. Jan 6, 2026AnnouncementOf this Current Report on Form 8-K. A copy of the related press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. Filing
  17. Nov 19, 2025AgreementAlkermes plc and Avadel Pharmaceuticals plc entered into Amendment No. 1 to the previously announced Transaction Agreement dated October 22, 2025 by and between Alkermes and Avadel (the “Original Transaction Agreement” and, as amended by the Amendment, the “Amended Transaction Agreement”). Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Alkermes financials

Famous investors that hold ALKS

5 of the 50 well-known investors we track reported holding ALKS in their latest 13F filing. The largest position is Jim Simons's, worth $263M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 20266.49M$263M0.4%+1%
Ken Griffin · Citadel AdvisorsQ3 20261.73M$70.1M0.0%+5%
Israel Englander · Millennium ManagementQ3 2026481,919$19.5M0.0%+51%
Ken Fisher · Fisher Asset ManagementQ3 2026433,263$17.6M0.0%+3%
Paul Tudor Jones · Tudor Investment CorpQ3 202687,074$3.5M0.0%+236%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Alkermes plc. (ALKS) stock

Who owns the most ALKS stock?

The largest reported owner of Alkermes plc. (ALKS) is BlackRock, Inc., with 17.5% of the company. In total, 422 funds and institutions reported holding ALKS at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are ALKS insiders buying or selling?

In the last 12 months, ALKS insiders reported no open-market purchases and 33 sales worth $10.1M. The latest trade was on Nov 3, 2026. See every trade.

What is the short interest in ALKS?

As of Oct 30, 2026, 19.65M ALKS shares were sold short, 11.7% of the shares outstanding, up 3.1% from the report before. At the average daily volume of 1.75M shares, buying them all back would take about 11.2 trading days (days to cover). See the history.

Have members of Congress traded ALKS?

Yes. 1 member of Congress reported 2 purchases and 0 sales of ALKS since Nov 17, 2024. The latest was reported on Oct 12, 2026. See the trades.

Which famous investors hold ALKS?

5 of the 50 well-known investors we track reported ALKS in their latest 13F filing, including Jim Simons, Ken Griffin, Israel Englander. The largest position is worth $263M. See all holders.

Executive pay

Alkermes's chief executive was paid a total of $7.9M for the year ended Dec 31, 2025, down 22% from $10.1M the year before. In the last 12 months, Alkermes's executives and directors bought no stock on the open market and sold $10.1M.

Chief executive, total pay$7.9MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$12.6MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$3.5MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.